UPLIZNA Becomes First FDA-Approved Treatment for IgG4-Related Disease

Read more

Sangamo and Lilly Partner on Capsid License for CNS Genomic Medicines

Read more

Boehringer Ingelheim Expands ADC Portfolio with New R&D Center in Basel

Read more

Neurona Therapeutics Raises $102M for NRTX-1001 Phase 3 Trial

Read more

Rilzabrutinib Receives Orphan Drug Designation for Two Rare Diseases

Read more

Novartis Gets FDA Accelerated Approval for Vanrafia in IgAN

Read more

Flagship Pioneering and Pfizer Partner to Develop Selective Inhibitors for Autoimmune Diseases

Read more

Astellas Partners with Japanese Cancer Foundation to Boost Oncology Research

Read more

EU Approves Pfizer’s RSV Vaccine ABRYSVO for Adults 18-59

Read more

Apellis Gets FDA Priority Review for EMPAVELI in C3G, IC-MPGN

Read more